Learn

How mushrooms are taking over the healthcare industry, and how investors can profit off of this. First we will talk...
Powered by Restream https://restream.io/ What's up Psychedelic Investors?!? We have some big news for you. Atai Life Sciences will be...
Atai Life Sciences is now the second psychedelic company to list on Nasdaq, with plans to raise $100 million for...
From Sir Paul McCartney to Joe Rogan, these celebrities all credit psychedelics with changing their lives....
The first study of its kind compares psilocybin and the antidepressant Lexapro in treating depression. The results are promising....
April 19th is Bicycle Day — the first documented case of a human experience on LSD taken by chemist Albert...
This week in psychedelic business news:psilocybin’s genome sequencing explored, psychedelics meet artificial intelligence, and more....
Psilocybin taken at low doses could have powerful antidepressant effects, according to new research findings....
GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment....